Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» depression
depression
Google’s sister company didn’t succeed in search for depression biomarker
MedCity News
Thu, 11/5/20 - 10:56 am
Google X
Alphabet
depression
biomarkers
R&D
Praxis raises $110M to advance 3 clinical-phase CNS drugs
Fierce Biotech
Tue, 07/28/20 - 10:48 am
Praxis Precision Medicines
GABAA positive allosteric modulator
depression
Orexo launches digital therapies for depression, alcohol misuse early in US
Pharmaforum
Fri, 07/17/20 - 10:46 am
Orexo
digital therapies
COVID-19
depression
alcoholism
FDA List Notes Drug Shortages Related to Intubation, Anxiety and Depression
BioSpace
Thu, 06/11/20 - 11:09 am
FDA
drug shortages
anxiety
depression
intubation
There May Be a New First-Line Treatment for Depression
Motley Fool
Thu, 04/30/20 - 10:37 am
Axsome Therapeutics
FDA
depression
AXS-05
Sage to lay off half of workforce in cost-cutting retrenchment
BioPharma Dive
Tue, 04/7/20 - 07:47 pm
SAGE Therapeutics
layoffs
depression
Zulresso
LivaNova and Verily in Research Agreement to Treat Depression
Medical Devices and Diagnostics Industry
Thu, 02/27/20 - 11:30 pm
LivaNova
Verily
Alphabet
vagus nerve stimulation
depression
devices
Sage rethinks SAGE-217 program after phase 3 failure
Fierce Biotech
Thu, 02/27/20 - 10:32 am
SAGE Therapeutics
clinical trials
depression
SAGE-217
Fisher Wallace files citizen petition over FDA’s class III designation for CES
BioWorld
Fri, 02/21/20 - 12:01 am
Fisher Wallace Labs
citizen petitions
FDA
cranial electrotherapy stimulation
depression
devices
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Fri, 12/13/19 - 11:02 am
Axsome Therapeutics
AXS-05
treatment-resistant depression
depression
Eli Lilly
pegilodecakin
lung cancer
China could quickly become the world’s largest antidepressant market, but hurdles remain
Marketwatch
Sun, 10/27/19 - 10:41 pm
China
antidepressants
depression
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
Fierce Pharma
Mon, 06/24/19 - 07:21 pm
JNJ
Spravato
Veteran's Affairs
Donald Trump
depression
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
Endpoints
Thu, 06/13/19 - 10:00 am
Donald Trump
JNJ
Spravato
depression
veterans
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
Thu, 05/23/19 - 10:45 pm
depression
ketamine
esketamine
Spravato
JNJ
Janssen
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Yahoo/Bloomberg
Wed, 05/15/19 - 10:26 am
Sanofi
digital pharma
Happify Health
digital therapeutics
depression
multiple sclerosis
J&J prices ketamine-like depression treatment at $590-$885 for two doses
Reuters
Fri, 03/8/19 - 09:35 am
JNJ
Spravato
depression
drug pricing
esketamine
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Fri, 11/9/18 - 12:05 am
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid
CNBC
Wed, 08/29/18 - 10:31 am
depression
ketamine
opioids
JNJ
Allergan
Diagnosing Depression By Blood Biomarkers: A Viable Approach?
Forbes
Tue, 07/31/18 - 10:21 am
depression
biomarkers
diagnostics
Nano Vision
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »